A revolutionary synthetic dermal template developed at the Royal Adelaide Hospital has completed a world-first multicentre clinical trial with positive results. The NovoSorb® Biodegradable Temporizing Matrix (BTM) is an artificial foam-like material that is used to...
Thousands of kidney transplant patients with incurable cancer may get a new lease on life thanks to new research from the Royal Adelaide Hospital and the University of South Australia. The world-first study shows that adding immunotherapy to standard anti-rejection...
A program to treat severe emphysema with cutting-edge technology has received a World-Class Care Award for Integrated Health Care during CALHN’s World Class Care Day. Endobronchial valves reduce inflated lung volumes in patients with limited treatment options, and the...
When Eliza was diagnosed with type 1 diabetes at just nine years old, she immediately told her mum that she wanted to be a diabetes educator. 20 years on, Eliza has achieved that dream becoming both a Diabetes Nurse Educator at CALHN, and a passionate advocate for...
Researchers at the Royal Adelaide Hospital (RAH) are investigating the next generation tumour imaging technique to better equip oncologists in the fight against fatal glioblastoma brain tumours. The FET-PET in Glioblastoma (FIG) study aims to compare traditional MRI...
South Australian researchers are trialling a nutritional intervention for obese men to improve fertility without requiring weight loss. Aiming to tackle the health risks that can be passed on to children by fathers who are obese at the time of conception, the Diet for...
